These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20649635)

  • 1. Effects of physical exercise versus rosiglitazone on endothelial function in coronary artery disease patients with prediabetes.
    Desch S; Sonnabend M; Niebauer J; Sixt S; Sareban M; Eitel I; de Waha S; Thiele H; Blüher M; Schuler G
    Diabetes Obes Metab; 2010 Sep; 12(9):825-8. PubMed ID: 20649635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease.
    Sixt S; Rastan A; Desch S; Sonnabend M; Schmidt A; Schuler G; Niebauer J
    Eur J Cardiovasc Prev Rehabil; 2008 Aug; 15(4):473-8. PubMed ID: 18677174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus.
    Sidhu JS; Cowan D; Kaski JC
    Am J Cardiol; 2004 Jul; 94(2):151-6. PubMed ID: 15246889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone increases adiponectin levels in nondiabetic patients with coronary artery disease.
    Patel SR; Mailloux LM; Coppola JT; Mindrescu C; Staniloae CS
    Coron Artery Dis; 2008 Aug; 19(5):349-53. PubMed ID: 18580598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
    Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
    Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance.
    Durbin RJ
    Diabetes Obes Metab; 2004 Jul; 6(4):280-5. PubMed ID: 15171752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.
    Esposito K; Ciotola M; Carleo D; Schisano B; Saccomanno F; Sasso FC; Cozzolino D; Assaloni R; Merante D; Ceriello A; Giugliano D
    Diabetes Care; 2006 May; 29(5):1071-6. PubMed ID: 16644639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
    Raji A; Gerhard-Herman MD; Williams JS; O'connor ME; Simonson DC
    Diabet Med; 2006 May; 23(5):537-43. PubMed ID: 16681563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome.
    Wang TD; Chen WJ; Cheng WC; Lin JW; Chen MF; Lee YT
    Am J Cardiol; 2006 Oct; 98(8):1057-62. PubMed ID: 17027571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aged garlic extract improves endothelial function in men with coronary artery disease.
    Williams MJ; Sutherland WH; McCormick MP; Yeoman DJ; de Jong SA
    Phytother Res; 2005 Apr; 19(4):314-9. PubMed ID: 16041725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, insulin, and endothelial function in overweight children and adolescents: the role of exercise.
    Kelly AS; Wetzsteon RJ; Kaiser DR; Steinberger J; Bank AJ; Dengel DR
    J Pediatr; 2004 Dec; 145(6):731-6. PubMed ID: 15580192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the Glitazones and the Endothelium (GATE) study: evaluation of rosiglitazone on endothelial function in patients with diabetes.
    Hubacek J; Verma S; Shewchuk L; Ross SJ; Edwards A; Anderson TJ
    Can J Cardiol; 2004 Dec; 20(14):1449-53. PubMed ID: 15614340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome.
    Wang TD; Chen WJ; Lin JW; Chen MF; Lee YT
    Am J Cardiol; 2004 Feb; 93(3):362-5. PubMed ID: 14759393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance.
    Lessard SJ; Rivas DA; Chen ZP; Bonen A; Febbraio MA; Reeder DW; Kemp BE; Yaspelkis BB; Hawley JA
    Diabetes; 2007 Jul; 56(7):1856-64. PubMed ID: 17440174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease.
    Warnholtz A; Ostad MA; Heitzer T; Goldmann BU; Nowak G; Munzel T
    Am J Cardiol; 2005 Jan; 95(1):20-3. PubMed ID: 15619388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction induced by statin contributes to endothelial dysfunction in patients with coronary artery disease.
    Dai YL; Luk TH; Siu CW; Yiu KH; Chan HT; Lee SW; Li SW; Tam S; Fong B; Lau CP; Tse HF
    Cardiovasc Toxicol; 2010 Jun; 10(2):130-8. PubMed ID: 20383667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or non-diabetic metabolic syndrome.
    Kim SG; Ryu OH; Kim HY; Lee KW; Seo JA; Kim NH; Choi KM; Lee J; Baik SH; Choi DS
    Eur J Endocrinol; 2006 Mar; 154(3):433-40. PubMed ID: 16498057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.